Omega Protein Reports 2009 Third Quart...(ng statements include among others: (1) ...),Health

Date:11/3/2009

ng statements include, among others: (1) the Company's ability to meet its raw material requirements through its annual menhaden harvest, which is subject to fluctuations due to natural conditions over which the Company has no control, such as varying fish population, fish oil yields, adverse weather conditions and disease; (2) the impact of worldwide supply and demand relationships on prices for the Company's products; (3) Omega Protein's expectations regarding demand and pricing for its products proving to be incorrect; (4) fluctuations in the Company's quarterly operating results due to the seasonality of the Company's business and its deferral of inventory sales based on worldwide prices for competing products; and (5) the impact of the uncertain economic conditions, both in the United States and globally. These and other factors are described in further detail in Omega's filings with the Securities and Exchange Commission, including its reports on Form 10-K, Form10-Q and Form 8-K. The Company also posts its latest internally generated price list for various products on its Company website, www.omegaproteininc.com. Pricing and product availability information disclosed in the price list are subject to change or discontinuance without prior notice, and the Company undertakes no obligation to update such information.

                             OMEGA PROTEIN CORPORATION
                              Statement of Operations
                                    (unaudited)

                                    Three Months               Nine Months
                                 Ended September 30,       Ended September 30,
                                 -------------------       -------------------
                                 2009           2008       2009         2008
                                 ----           ----       ----         ----
                                  (in thousand
'/>"/>
SOURCE  Omega Protein Corporation
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 
Related medicine news :

1. Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report
2. FDA Approves Valcyte(R) (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
3. New Omega-3 Blood Test: A Better Predictor of Coronary Heart Disease Than Cholesterol
4. Omega Protein Reports 2009 Second Quarter Results
5. Omega-3 Fatty Acid Falls Short in Alzheimers Trials
6. Omega-3s Benefit Heart Attack Survivors, Healthy Adults, Mothers and Infants
7. Omega Medical Solutions Selects Allscripts Practice Management and Allscripts Payerpath Revenue Cycle Management
8. Omega-3 Fatty Acid Deficiency takes 96,000 Lives Annually in the US
9. Omega-3 Fatty Acids Key to Fetal Development - Possible Mercury Contamination Concerns in Some Fish Oil Avoided With Plant-based DHA in PreNexa(R) Prenatal Vitamins
10. Nordic Omega-3 Fishies from Nordic Naturals Offers Quality EPA and DHA for Children with Kid Pleasin Taste
11. Omega-3 Fatty Acids Might Curb Depression in Heart Patients